Difficulty: Medium
Average Score: 62%
Practice
A patient with coronary artery disease has raised serum triglyceride (600 mg/dl) but normal total cholesterol level (150 mg/dl). Which hypolipidemic drug should be prescribed
Correct answer
B
Rationale
In this scenario, the correct answer is B) Gemfibrozil. Gemfibrozil is a fibric acid derivative commonly used to reduce high levels of triglycerides in the blood. Triglycerides are a type of fat found in the blood, and elevated levels are associated with an increased risk of cardiovascular disease, especially in patients with coronary artery disease. Gemfibrozil works by decreasing the production of triglycerides in the liver and increasing the removal of triglycerides from the blood.
Option A) Propranolol is a beta-blocker commonly used to treat hypertension and certain heart conditions, but it does not have a significant effect on lipid levels.
Option C) Cholestyramine is a bile acid sequestrant that works by binding to bile acids in the intestine, but it is more effective in lowering cholesterol levels rather than triglycerides.
Option D) Lovastatin is a statin medication that primarily targets lowering LDL cholesterol levels. While it may have some effect on triglyceride levels, it is not as effective as fibric acid derivatives like gemfibrozil in lowering triglycerides.
Educational Context: Understanding the rationale behind selecting the appropriate hypolipidemic drug based on the lipid profile of the patient is crucial in the management of cardiovascular diseases. Different classes of medications target specific lipid abnormalities, and choosing the right drug based on the individual patient's lipid profile can help optimize treatment outcomes and reduce cardiovascular risk factors. Gemfibrozil, in this case, is the most appropriate choice for reducing elevated triglyceride levels in a patient with coronary artery disease, ultimately improving their cardiovascular health.
Option A) Propranolol is a beta-blocker commonly used to treat hypertension and certain heart conditions, but it does not have a significant effect on lipid levels.
Option C) Cholestyramine is a bile acid sequestrant that works by binding to bile acids in the intestine, but it is more effective in lowering cholesterol levels rather than triglycerides.
Option D) Lovastatin is a statin medication that primarily targets lowering LDL cholesterol levels. While it may have some effect on triglyceride levels, it is not as effective as fibric acid derivatives like gemfibrozil in lowering triglycerides.
Educational Context: Understanding the rationale behind selecting the appropriate hypolipidemic drug based on the lipid profile of the patient is crucial in the management of cardiovascular diseases. Different classes of medications target specific lipid abnormalities, and choosing the right drug based on the individual patient's lipid profile can help optimize treatment outcomes and reduce cardiovascular risk factors. Gemfibrozil, in this case, is the most appropriate choice for reducing elevated triglyceride levels in a patient with coronary artery disease, ultimately improving their cardiovascular health.